#6100
Aspergillus
fumigatus IgG ELISA
ELISA kit for the diagnosis of human aspergillosis
Lot 2331A (Expiry date: 24.05.2025)
Production date : 25.09.2023
Results of quality control 3 (after
12 months), date: 19.09.2024
No serum blank (average) : 0.121
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.003 |
0.001 |
-0.003 |
0.004 |
0.000 |
0 |
Negative control serum
(N° 6100-06) |
0.044 |
0.038 |
0.042 |
0.048 |
0.043 |
2 |
Weak positive serum
(N° 6100-07) |
0.652 |
0.699 |
0.618 |
0.648 |
0.655 |
30 |
Positive control
serum
(N° 6100-08) |
2.098 |
2.176 |
2.196 |
2.324 |
2.199 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 6100-08 |
> 1.200 |
2.199 |
Yes |
Absorbance of weak positive serum 6100-07, as % of positive serum
|
> 11 % |
30 % |
Yes |
Absorbance of negative serum 6100-06, as % of positive serum |
< 8 % |
2 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.121 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|